Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports it will present at the International Association for Chemical Testing (IACT) conference. Cannabix’s Dr. Bruce Goldberger, a UF professor, will present on Science & Technology Behind Cannabis Breath Testing and the company’s marijuana breathalyzer system at the conference workshop session.
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands Product Series to Breath Logix
UF startup Cannabix Technologies Inc., developer of marijuana and alcohol breath-testing devices reports that it has shipped its Industrial Series Contactless Alcohol Breathalyzers (“CAB” devices) for certification testing and is rebranding the “CAB” name under the new “Breath Logix” product series, part of the company’s portfolio of marijuana and alcohol screening devices.
Cannabix Technologies Participates in New Southern United States Study With Marijuana Breathalyzer Technology
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace reports that the Company is participating in a new comprehensive multi-analysis study of subjects under the influence of marijuana. The new study will work along side toxicologists and law enforcement officers in the southern United States.
Cannabix Technologies To Present at Breath Summit 2022 – International Association of Breath Research (IABR)
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace reports that it will be attending and presenting its research: Correlation of Breath and Blood Cannabis Levels Using Custom-Made Breath Sample Collection and Analysis Methods at Breath Summit 2022 hosted by the International Association of Breath Research (IABR) in mid-June 2022.
Cannabix Technologies Develops Version 4.0 of THC Breath Analyzer Device
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace has reported that it has assembled its version 4.0 THC Breath Analyzer (“THCBA”) prototype and portable system for field use.
Cannabix Achieves New Benchmark for FAIMS Marijuana Breathalyzer Technology
UF startup Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports that engineers have made major advancements on its high-field asymmetric waveform ion mobility spectrometry (FAIMS) breathalyzer for analyze sensitivity and portability.
Cannabix Technologies Ramps Up Beta Testing With THC Breathalyzer and Ships Additional Devices
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it is ramping up subject beta testing in a high-volume clinic in the Northwestern US and will ship an additional THC Breath Analyzer (THCBA) unit to the site.
Cannabix Technologies Granted U.S. Patent for FAIMS Molecular Analysis Device
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, is pleased to report that the United States Patent and Trademark Office (USPTO) has granted patent No. 17/019728 entitled, “Apparatus and Methods for Detection of Molecules” to the company.
Cannabix: Developing a Solution for Outdated Marijuana Testing
UF startup Cannabix Technologies Inc., a Canadian company that is developing marijuana breathalyzer technology, believe their innovations will help law enforcement officers detect THC-impairment of drivers, ultimately making it easier to prosecute offenders.
Cannabix Technologies Granted Cannabis Drug Detection Device Canadian Patent, Delivers THCBA to US Clinic
UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, announces that the Canadian Intellectual Property Office (CIPO) has granted patent No. 2887841 entitled, “Cannabis Drug Detection Device”.
